Funding tracker

Ansa Biotechnologies raised $71.5M

$71.5MRaised
Series CStage
18 Nov 2026Date
127Views on the announcement

The round

Amount$71.5M
StageSeries C
Investorsnot stated
What they doEnzymatic DNA synthesis
VerticalHealth and bio
First reportedWednesday, 18 November 2026

The announcement on X

The median tracked announcement from accounts with under 10K followers reached 13.4K views (201 posts). This one did 0.01x that.

Ansa Biotechnologies has closed a $71.5 million oversubscribed Series C financing, bringing our total funding to $211 million. Read the full press release at https://t.co/W47INyXvTt https://t.co/8f9FZe8M9S
Posted by@AnsaBio (Ansa Biotechnologies)
Followers1,376
Views127
Views per follower0.09x
Likes4
Reposts0
Bookmarks0

Similar rounds

CompanyStageAmountLeadOn XDate
IsomorphicAI drug discoverySeries C$5B--18 Nov 2026
PayhawkSpend management platformSeries C$280MGoldman Sachs, Goldman Sachs Growth-18 Nov 2026
BoltzAI drug design softwareSeries A$110MBessemer61.1K18 Nov 2026
TesoraiAI-powered life sciences research platformSeed$5.3M-3118 Nov 2026
PulmoGateNagoya University AI spinoutSeed$3.3M--18 Nov 2026
Science CorporationSeries D$400M--17 Nov 2026

Next launch

Planning a launch?

Tell us what is launching and when. Thirty minutes is usually enough to know whether we are the right team for it.